Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Prepaid Assets (2017 - 2025)

Historic Prepaid Assets for Protagonist Therapeutics (PTGX) over the last 9 years, with Q3 2025 value amounting to $9.7 million.

  • Protagonist Therapeutics' Prepaid Assets rose 2082.5% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year increase of 2082.5%. This contributed to the annual value of $7.7 million for FY2024, which is 9515.15% up from last year.
  • As of Q3 2025, Protagonist Therapeutics' Prepaid Assets stood at $9.7 million, which was up 2082.5% from $8.7 million recorded in Q2 2025.
  • In the past 5 years, Protagonist Therapeutics' Prepaid Assets ranged from a high of $9.7 million in Q3 2025 and a low of $3.5 million during Q2 2023
  • Moreover, its 5-year median value for Prepaid Assets was $7.7 million (2024), whereas its average is $7.2 million.
  • As far as peak fluctuations go, Protagonist Therapeutics' Prepaid Assets plummeted by 6398.52% in 2023, and later soared by 9665.81% in 2024.
  • Protagonist Therapeutics' Prepaid Assets (Quarter) stood at $9.5 million in 2021, then crashed by 39.73% to $5.7 million in 2022, then crashed by 30.67% to $4.0 million in 2023, then skyrocketed by 95.15% to $7.7 million in 2024, then rose by 25.83% to $9.7 million in 2025.
  • Its Prepaid Assets was $9.7 million in Q3 2025, compared to $8.7 million in Q2 2025 and $8.7 million in Q1 2025.